Clinical Trials
Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib Through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid Arthritis
Gilead Sciences
PR-M10-19-NI-017Oct 11, 2019
Collaboration
Gilead and Galapagos Enter Into Transformative Research and Development Collaboration
Gilead Sciences
PR-M07-19-NI-046Jul 18, 2019